Drug‐Induced Peripheral Neuropathy | Zendy

Vilholm Ole Jakob | Zendy; Christensen Alex Alban | Zendy; Zedan Ahmed Hussein | Zendy; Itani Mustapha | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Drug‐Induced Peripheral Neuropathy

Author(s) -

Vilholm Ole Jakob,

Christensen Alex Alban,

Zedan Ahmed Hussein,

Itani Mustapha

Publication year - 2014

Publication title -

basic and clinical pharmacology and toxicology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.805

H-Index - 90

eISSN - 1742-7843

pISSN - 1742-7835

DOI - 10.1111/bcpt.12261

Subject(s) - drug , peripheral neuropathy , medicine , peripheral , pharmacology , endocrinology , diabetes mellitus

Peripheral neuropathy can be caused by medication, and various descriptions have been applied for this condition. In this MiniReview, the term ‘drug‐induced peripheral neuropathy’ ( DIPN ) is used with the suggested definition: Damage to nerves of the peripheral nervous system caused by a chemical substance used in the treatment, cure, prevention or diagnosis of a disease. Optic neuropathy is included in this definition. A distinction between DIPN and other aetiologies of peripheral neuropathy is often quite difficult and thus, the aim of this MiniReview is to discuss the major agents associated with DIPN .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research